Get started
Author

Ahmet Baklaci

Observed name: Ahmet Baklacı
Observed institution: Adnan Menderes University
ORCID: 0009-0009-3897-3055
Observed ORCID: 0009-0009-3897-3055
OpenAlex ID: A5126628340
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
Prognostic factors affecting survival in early-stage HER2-positive breast cancer treated with adjuvant therapy
2026 · Ahmet Baklacı, Gamze Gokoz Dogu, et al. · Pamukkale Medical Journal
PDF
Prognostic Impact of Immune-Inflammatory and Nutritional Indices in Metastatic Hormone-Sensitive Prostate Cancer
2026 · Mehmet Nuri Baser, Ahmet Baklaci, et al. · Diagnostics
Preoperative Lactate Dehydrogenase-to-Albumin Ratio as a Tumor–Host Biomarker of Early Recurrence and Survival in Resected Pulmonary Neuroendocrine Carcinomas: A Multicenter Observational Cohort Study
2026 · Hacer Boztepe Yesilcay, Asim Armagan Aydin, et al. · Medicina
Works count: 4
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type